Oric Pharmaceuticals
ORIC
ORIC
143 hedge funds and large institutions have $442M invested in Oric Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.11% more ownership
Funds ownership: 107.4% → 111.52% (+4.1%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
28% less capital invested
Capital invested by funds: $612M → $442M (-$170M)
Holders
143
Holding in Top 10
5
Calls
$74K
Puts
$25K
Top Buyers
| 1 | +$12M | |
| 2 | +$7.81M | |
| 3 | +$4.92M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$4.48M |
| 5 |
O
OrbiMed
New York
|
+$3.91M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$10.2M | |
| 3 | -$6.76M | |
| 4 |
SCM
Superstring Capital Management
New York
|
-$4.25M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.04M |
